Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, neoplasm	Not yet recruiting	Phase 2 / Phase 3	2026-02-27		NCT07437287

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Alligator Bioscience AB	3
UNICANCER	111

22 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
APHM - CHU La Timone	Marseille	France	3
APHP - Hopital Beaujon	Paris	France	1
Centre Eugène Marquis	Rennes	France	37
Centre François Baclesse	Caen	France	39
Centre Léon Bérard	Lyon	France	71
Centre Paul Strauss	Strasbourg	France	27
CHU Brest	Brest	France	37
CHU de Bordeaux - Hopital Haut Leveque	Bordeaux	France	1
Chu de Dijon	Dijon	France	24
CHU de Lyon	Lyon	France	10
Chu Estaing	Clermont-Ferrand	France	18
CHU Grenoble Alpes	Grenoble	France	25
CHU Hotel Dieu	Nantes	France	3
CHU Lille	Lille	France	63
CHU Montpellier - Hôpital Saint Eloi	Montpellier	France	2
CHU Poitiers	Poitiers	France	70
CHU Tours	Tours	France	36
Hopital du Confluent	Nantes	France	2
Institut Curie	Paris	France	44
Institut de cancérologie de l'Ouest - Site Paul Papin	Angers	France	1
Institut de Cancérologie de Lorraine	Vandœuvre-lès-Nancy	France	19
Institut Jean Godinot	Reims	France	20

Clinical trials